| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $28.42M | - | |
| Other | 193.8K | $6.62M | - | |
| VP | 156.1K | $5.33M | - | |
| Dir | 150.1K | $5.13M | - | |
| Dir | 149.9K | $5.12M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Davis John E | Chief Commercial Officer | Sell | 5,000 | $45.11 | $225,550.00 | -2.5% | |
| Dec 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 4,572 | $44.42 | $203,083.67 | -3.4% | |
| Dec 3, 2025 | MacKin James P | President &CEO | Sale+OE | 30,921 | $45.46 | $1,405,699.58 | -3.7% | |
| Dec 3, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 7,315 | $45.30 | $331,369.50 | -2.3% | |
| Dec 2, 2025 | MacKin James P | President &CEO | Sale+OE | 30,921 | $45.56 | $1,408,729.84 | -3.7% | |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sale+OE | 47,376 | $45.04 | $2,133,920.12 | -19.7% | |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sale+OE | 15,276 | $44.18 | $674,825.40 | -10.2% | |
| Nov 18, 2025 | Hoff Elizabeth A | Director | Sell | 4,200 | $45.10 | $189,411.60 | -13.4% | |
| Nov 17, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 6,000 | $45.73 | $274,380.00 | -4.2% | |
| Nov 17, 2025 | Davis John E | Chief Commercial Officer | Sale+OE | 12,787 | $44.92 | $574,392.29 | -3.1% |